ALINS Intrasense

Regulatory News:

Intrasense (Paris:ALINS), an international leader in multimodal medical imaging software, announces the signature of a global OEM agreement with Cerner, one of the largest health care IT providers.

The agreement includes the integration of the Myrian® medical imaging software solution into the Cerner PACS offering (Picture Archiving and Communication System). Myrian® is a vendor-neutral solution for interpreting, analyzing and sharing medical images, notably in the field of oncology.

Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals. Through this agreement, Cerner will distribute the Myrian® technology as part of their product portfolio with a rollout on a global basis.

“Intrasense offers a proven product that has already convinced a great number of our clients. This expanded offering through Myrian® enlarges our portfolio and offers a robust visualization solution to our existing and future clients” said Andre Neu, Director of European Imaging with Cerner.

Patrick Mayette, Intrasense CEO, adds: “We are proud to have such a collaboration with one of the major actors on the market. This OEM agreement is highly important for both Cerner and Intrasense and we will cooperate to build an ever-stronger value proposition through the smart combination of our products. Users will benefit from the added capabilities this partnership will provide to their operations."

About Intrasense:Intrasense designs, develops and markets Myrian®, a unique, vendor-neutral software suite for the visualization and advanced processing of multimodal medical images such as MRI, CT scans, PET, X-rays, and more. Developed with leading academic and scientific partners, Myrian® combines and uses all of the various medical images to extract information vital to the patient's care, to evaluate treatment efficiency and to assess drug candidates in oncology and other pathologies. With more than 700 client sites around the world, Myrian® has been certified as a "medical device" in over 40 countries including the United States (FDA), Europe (CE) and Asia. Intrasense SA is listed on the Alternext (FR0011179886 - ALINS).For more about Intrasense, please visit www.intrasense.fr and follow us on LinkedIn.

About Cerner:Cerner is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. We started with the foundation of digitizing paper processes and now offer the most comprehensive array of information software, professional services, medical device integration, remote hosting and employer health and wellness services. Cerner systems are used by everyone from individual consumers, to single-doctor practices, hospitals, employers and entire countries. Taking what we've learned over more than three decades, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care.Cerner® solutions are licensed by approximately 10,000 facilities around the world, including more than 2,700 hospitals; 4,150 physician practices; 45,000 physicians; 550 ambulatory facilities, such as laboratories, ambulatory centers, behavioral health centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 45 employer sites and 1,750 retail pharmacies.For more information about Cerner, please visit www.cerner.com, Twitter, Facebook and YouTube.

IntrasensePatrick MayetteCEOChristophe LamboeufChief Financial OfficerPhone : +33(0)1 48 04 32 83investisseurs@intrasense.frorNewCap.Financial Communication and Investor RelationsValentine Brouchot / Pierre LaurentPhone : +33(0)1 44 71 98 52intrasense@newcap.frorCernerJulia H�nigMarketingPhone : +33 (0)1 76 74 09 70julia.hoenig@cerner.com

Intrasense (EU:ALINS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Intrasense (EU:ALINS)
Historical Stock Chart
From Jan 2024 to Jan 2025